• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢吡肟的表征、性质及分析方法综述

Review on Characterization, Properties, and Analytical Methods of Cefepime.

作者信息

Al Kamaly Omkulthom

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.

出版信息

Int J Anal Chem. 2022 Jun 29;2022:6909528. doi: 10.1155/2022/6909528. eCollection 2022.

DOI:10.1155/2022/6909528
PMID:35814263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9259364/
Abstract

Infection is one of the most important reasons for the increase in the number of deaths worldwide; it can be a bacterial or viral infection. As a result, there are many effective drugs against this infection, especially bacterial ones. Cefepime (CP) is one of the fourth generations of cephalosporins and is distinguished from others in that it can kill both positive and negative bacteria. Therefore, this study focused on the chemical properties of the drug, its uses, and its stability against bacteria. All analysis methods for this drug in pharmaceutical preparations, blood, or plasma were also presented. One of the important problems in these methods is using toxic solvents, which poses a danger to society and the environment. The presentation of these solvents will allow companies to manufacture and use more effective and less toxic solvents.

摘要

感染是全球死亡人数增加的最重要原因之一;它可以是细菌感染或病毒感染。因此,有许多针对这种感染的有效药物,尤其是针对细菌感染的药物。头孢吡肟(CP)是第四代头孢菌素之一,与其他头孢菌素的区别在于它既能杀死阳性菌又能杀死阴性菌。因此,本研究聚焦于该药物的化学性质、用途及其对细菌的稳定性。还介绍了该药物在药物制剂、血液或血浆中的所有分析方法。这些方法中的一个重要问题是使用有毒溶剂,这对社会和环境构成危险。介绍这些溶剂将使公司能够生产和使用更有效且毒性更小的溶剂。

相似文献

1
Review on Characterization, Properties, and Analytical Methods of Cefepime.头孢吡肟的表征、性质及分析方法综述
Int J Anal Chem. 2022 Jun 29;2022:6909528. doi: 10.1155/2022/6909528. eCollection 2022.
2
Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢吡肟:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1994 Mar;47(3):471-505. doi: 10.2165/00003495-199447030-00007.
3
Cefepime: a review of its use in the management of hospitalized patients with pneumonia.头孢吡肟:用于住院肺炎患者治疗的综述
Am J Respir Med. 2003;2(1):75-107. doi: 10.1007/BF03256641.
4
Cefepime: a new fourth-generation cephalosporin.头孢吡肟:一种新型第四代头孢菌素。
Am J Hosp Pharm. 1994 Feb 15;51(4):463-77; quiz 541-2.
5
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.头孢地尔:一种具有抗碳青霉烯类和多药耐药革兰氏阴性杆菌活性的铁载体头孢菌素。
Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2.
6
Evaluation of the in vitro Activity of Two Fourth-Generation Cephalosporins Against Bacterial Samples Isolated From Patients in Several Brazilian Hospitals.
Braz J Infect Dis. 1999 Oct;3(5):189-196.
7
Cefepime microbiologic profile and update.
Pediatr Infect Dis J. 2001 Mar;20(3):331-6. doi: 10.1097/00006454-200103000-00031.
8
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.八种广谱β-内酰胺类药物的抗菌活性及谱研究:1997年在美国102个医疗中心进行的一项监测试验。头孢吡肟研究组。
Diagn Microbiol Infect Dis. 1998 Mar;30(3):215-28. doi: 10.1016/s0732-8893(97)00234-4.
9
Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.一种新型胃肠外抗生素在严重细菌感染治疗中的临床应用。
Am J Med. 1996 Jun 24;100(6A):52S-59S. doi: 10.1016/s0002-9343(96)00108-8.
10
In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
Pharmazie. 2004 Nov;59(11):854-8.

本文引用的文献

1
Cefepime Induced Neurotoxicity Following A Regimen Dose-Adjusted for Renal Function: Case Report and Review of the Literature.根据肾功能调整方案剂量后头孢吡肟引起的神经毒性:病例报告及文献综述
Hosp Pharm. 2022 Jun;57(3):385-391. doi: 10.1177/00185787211046856. Epub 2021 Sep 16.
2
Clinical effectiveness of beta-lactams versus fluoroquinolones as empirical therapy in patients with diabetes mellitus hospitalized for urinary tract infections: A retrospective cohort study.β-内酰胺类与氟喹诺酮类作为糖尿病住院患者尿路感染经验性治疗的临床疗效:一项回顾性队列研究。
PLoS One. 2022 Mar 31;17(3):e0266416. doi: 10.1371/journal.pone.0266416. eCollection 2022.
3
Role of internal loop dynamics in antibiotic permeability of outer membrane porins.
内膜环动力学在外膜孔道抗生素渗透性中的作用。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2117009119.
4
Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible .经验性抗生素治疗对非敏感性门诊尿路感染结局的影响。
Microbiol Spectr. 2022 Feb 23;10(1):e0235921. doi: 10.1128/spectrum.02359-21. Epub 2022 Feb 9.
5
Multicenter surveillance of activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against , and complex causing bloodstream infection in Taiwan, 2020.2020 年台湾地区多中心监测头孢吡肟-齐他培南、头孢吡肟-恩他培南、奥马环素、依拉环素及对照抗生素对血流感染的 和 复合体的活性。
Expert Rev Anti Infect Ther. 2022 Jun;20(6):941-953. doi: 10.1080/14787210.2022.2021876. Epub 2022 Jan 11.
6
Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt.头孢他啶和头孢吡肟治疗新冠肺炎患者的疗效:来自埃及的单中心报告
Antibiotics (Basel). 2021 Oct 20;10(11):1278. doi: 10.3390/antibiotics10111278.
7
The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli.新型β-内酰胺酶抑制剂他尼硼巴坦恢复产 KPC 大肠埃希菌中头孢吡肟的形态学效应。
Microbiol Spectr. 2021 Oct 31;9(2):e0091821. doi: 10.1128/Spectrum.00918-21. Epub 2021 Sep 8.
8
Extended Spectrum Beta-Lactamase (ESBL) Produced by Gram-Negative Bacteria in Trinidad and Tobago.特立尼达和多巴哥革兰氏阴性菌产生的超广谱β-内酰胺酶(ESBL)
Int J Microbiol. 2021 Aug 23;2021:5582755. doi: 10.1155/2021/5582755. eCollection 2021.
9
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.采用小鼠大腿感染模型,对美罗培南、头孢吡肟或氨曲南与新型β-内酰胺酶抑制剂那库巴坦联合用药,针对耐碳青霉烯类和/或产碳青霉烯酶的肺炎克雷伯菌和大肠埃希菌进行药效学评价。
Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28.
10
Cefepime-Induced Encephalopathy.头孢吡肟诱发的脑病
Cureus. 2021 Feb 4;13(2):e13125. doi: 10.7759/cureus.13125.